• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

News Reports And Fair Dealing: Moneyweb v Media24

19/05/2016 by Intellectual Property Watch 1 Comment

The recent decision involving Moneyweb and Media24 (Moneyweb (Pty) Limited v Media 24 Limited & Another [2016] ZAGPJHC 81) is an important one for copyright lawyers in South Africa because it is the first time that two provisions relating to news reporting of the Copyright Act 1978 (the Act) have been judicially considered, namely, sections 12(1)(c)(i) and 12(8)(a). In fact, it is the first time that the application of the fair-dealing provision, section 12(1), has received any judicial consideration, whether in the context of news reporting or otherwise.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Africa, Copyright Policy, English, IP Law, Information and Communications Technology/ Broadcasting, Regional Policy

Washington Post- Colombia Battles World’s Biggest Drugmaker Over Cancer Drug

19/05/2016 by Intellectual Property Watch Leave a Comment

[From the Washington Post] BOGOTA, Colombia — Colombia’s government is giving pharmaceutical giant Novartis a few weeks to lower prices on a popular cancer drug or see its monopoly on production of the medicine broken and competition thrown open to generic rivals.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, English, Europe, Health & IP, Latin America/Caribbean, Lobbying, North America, Outside Sources, Patents/Designs/Trade Secrets, Regional Policy

The Bipolar Nature Of Academic Publishing

05/05/2016 by Intellectual Property Watch 1 Comment

Since the late twentieth-century shift from the liberal university to the neoliberal university (the latter distinguished by the managerial class installed to leverage and extract value from academic research, plus polish the brand of the franchise), the publications’ ecosystem for academics, foremost in the Arts and Humanities, has been altered beyond recognition. Notably, it has exponentially expanded while at the same time suffering maximum constriction in the form of what legal scholars have called the “great copyright robbery” (Bernt Hugenholtz, 2000), writes Gavin Keeney.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Access to Knowledge/ Education, Copyright Policy, English, Finance, WIPO

Infojustice.org – Australian Commission Recommends Fair Use To Restore Balance In Copyright Law

03/05/2016 by Intellectual Property Watch 1 Comment

Infojustice.org reports: A draft report by the Australian Productivity Commission (APC) concludes that the current copyright law fails to properly balance the interests of copyright holders and users. It warns that “Australia’s copyright arrangements are weighed too heavily in favour of copyright owners, to the detriment of the long-term interests of both consumers and intermediate users.” The APC makes recommends changes to the law to address the imbalance, including “the introduction of a broad, principles-based fair use exception.”

Filed Under: IP-Watch Briefs, IP Policies, Themes, Venues, Access to Knowledge/ Education, Asia/Pacific, Copyright Policy, Information and Communications Technology/ Broadcasting, Outside Sources, Regional Policy

Surprise! Much Work Being Done On Transparency Of Patents On Medicines

28/04/2016 by Intellectual Property Watch Leave a Comment

James Love writes: In a recent paper by Reed F. Beall and Amir Attaran [KEI’s April 12, 2016 comment here: http://www.keionline.org/node/2467], and in the WIPO seminar discussions about the paper, the authors have held themselves out as more or less lonely voices calling for transparency of patent landscapes on essential medicines. This surprised and offended the many people who have not only been concerned about the lack of transparency on patent landscapes, but have been doing most of the work in digging out the facts, and/or proposing remedies.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, English, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, WHO

Why We Celebrated World Intellectual Property Day 2016

27/04/2016 by Intellectual Property Watch Leave a Comment

Corey Salsberg writes: Yesterday was World Intellectual Property Day. April 26 is the day we celebrate and call attention to the global intellectual property (IP) system. Why do we set aside a day for the entire world to stop and reflect on a subject that, for many, may seem more at home in board rooms, lecture halls, and legislatures, than in cafes, farms, and internet blogs?

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, Access to Knowledge/ Education, Development, English, Innovation/ R&D, Latin America/Caribbean, Patents/Designs/Trade Secrets, Regional Policy, Technical Cooperation/ Technology Transfer, WIPO

Drawn Out Battle Over Genetic Resources Dampens Africa’s Hopes

27/04/2016 by Intellectual Property Watch 2 Comments

Chidi Oguamanam writes: The global South is full of significant, diverse biological and genetic resources. It’s also home to most of the world’s indigenous communities. This is why developing countries are sensitive about protecting their genetic resources and traditional knowledge.

Indigenous communities enjoy a close relationship with nature. Genetic resources are central to producing their traditional knowledge. This drives innovations in agriculture, medicines and conservation. But global intellectual property frameworks – the legal mechanisms for securing knowledge ownership – still haven’t taken this reality into account.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, Africa, Biodiversity/Genetic Resources/Biotech, Copyright Policy, English, Patents/Designs/Trade Secrets, Regional Policy, Trademarks/Geographical Indications/Domains, Traditional and Indigenous Knowledge, WIPO, WTO/TRIPS

Failsafe Tips For Identifying And Developing Potentially Valuable Patents

20/04/2016 by Intellectual Property Watch 2 Comments

It’s easy to find valuable and useful patents, if you have small patent portfolios, but it can be a daunting task when portfolios contain hundreds or thousands of patents. Yet this task is critical for any business, and especially for technology companies that typically hold significant portfolios.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, English, Innovation/ R&D, North America, Patents/Designs/Trade Secrets, Regional Policy

Tribute To Brazilian Legal Scholar Denis Barbosa

05/04/2016 by Intellectual Property Watch, Intellectual Property Watch 1 Comment

Genius, brilliant, generous, wholehearted, warm, kind, funny, original, musician, art lover, brave, restless, these are few of the most suitable and recurrent attributes of Denis Borges Barbosa, who passed away on Saturday, April 2nd. Leading IP professor, researcher and attorney in Brazil, he was also the key international face of Brazilian IP, write Allan Rocha de Souza and Cláudia Chamas.

Filed Under: IP Policies, Language, Themes, Venues, Copyright Policy, English, IP Law, Innovation/ R&D, Latin America/Caribbean, Patents/Designs/Trade Secrets, Regional Policy, Technical Cooperation/ Technology Transfer, Trademarks/Geographical Indications/Domains, WTO/TRIPS

China’s Pharmaceutical Sector And The IP Puzzle

15/03/2016 by Intellectual Property Watch Leave a Comment

Despite impressive growth, the pharmaceutical sector in China still relies on generic drug production since the majority of domestic companies cannot compete with country-based foreign corporations. Currently, following WTO pressure to oblige China to comply with IP regulations, more and more patented drugs are entering the market. Unfortunately, in spite of a newly introduced IP friendly bill, a puzzling situation persists, writes Pietro Dionisio.

Filed Under: Features, Inside Views, IP Policies, Language, Themes, Venues, Asia/Pacific, Enforcement, English, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, Regional Policy

  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 43
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting